Los Angeles Capital Management LLC Maxcyte, Inc. Transaction History
Los Angeles Capital Management LLC
- $28.5 Billion
- Q3 2025
A detailed history of Los Angeles Capital Management LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 63,330 shares of MXCT stock, worth $100,061. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,330
Previous 63,330
-0.0%
Holding current value
$100,061
Previous $138,000
27.54%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
71.8MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY8.23MShares$13 Million0.78% of portfolio
-
Mirabella Financial Services LLP London, X08.2MShares$13 Million1.16% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$12.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY6.7MShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.59MShares$8.83 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $161M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...